Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adverum Biotechnologies
Biotech
Adverum's gene therapy reduces treatment burden in wet AMD
Adverum’s ixo-vec, a gene therapy for wet AMD, has demonstrated a reduction in treatment burden and maintained visual acuity in a phase 2 study.
Gabrielle Masson
Feb 8, 2024 11:17am
Leaps by Bayer chief jumps to Bayer, too—Chutes & Ladders
Aug 25, 2023 9:30am
Adverum lays off staff, funnels cash to single eye candidate
Jul 7, 2022 2:27pm
Gyroscope spins the wheel again as it taps Sanofi for $60M
Nov 8, 2021 9:10am
Half of Adverum eye disease pipeline 'snaps out of existence'
Jul 23, 2021 5:34am
Biotech earnings season clouded by COVID, lifted by gene editing
Jul 21, 2021 10:01am